Real-world use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/β-blocks in Chinese patients before acute myocardial infarction occurs: patient characteristics and hospital follow-up.
Xu-He GongXiaosong DingHui ChenHongwei LiPublished in: Journal of translational medicine (2018)
The in-hospital MACE was similar between AAβ treated patients and no-AAβ treated patients. However, treatment with AAβ before AMI was associated with improved heart function and smaller infarct size.
Keyphrases
- angiotensin converting enzyme
- acute myocardial infarction
- newly diagnosed
- end stage renal disease
- ejection fraction
- angiotensin ii
- healthcare
- emergency department
- prognostic factors
- heart failure
- coronary artery disease
- left ventricular
- percutaneous coronary intervention
- case report
- atrial fibrillation
- patient reported
- combination therapy
- drug induced